[Cases of congenital eye malformations in children]

Monika Modrzejewska1, Ewelina Lachowicz, Danuta Karczewicz

  • 1Katedra i Klinika Okulistyki Pomorskiego Uniwersytetu Medycznego w Szczecinie, al. Powstańców Wlkp. 72, 70-111 Szczecin.

Insights

Congenital eye defects in infants often accompany other systemic developmental anomalies. Early detection and a multidisciplinary approach are crucial for managing these complex conditions.

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Genetics

Context:

  • Congenital eye anomalies are a significant concern in infantile development.
  • A retrospective analysis of 1507 infants was conducted.
  • Focus was placed on nine infants (0.6%) with congenital eye defects.

Purpose:

  • To describe the clinical presentation of congenital eye defects.
  • To identify coexisting systemic developmental anomalies in affected children.
  • To analyze potential contributing factors to ocular pathology.

Summary:

  • Congenital anomalies of the anterior and posterior eye segments were identified, including corneal defects, iris coloboma, aniridia, persistent hyperplastic primary vitreous (PHPV), and optic nerve coloboma.
  • Three children presented with both anterior and posterior segment anomalies, along with microphthalmia, nystagmus, and strabismus.
  • Six children had coexisting systemic anomalies affecting the heart, nervous system, osteoarticular system, genitourinary system, auditory organ, and skin. One case showed an abnormal karyotype (49, XXXXX).

Impact:

  • Highlights the frequent association between congenital eye anomalies and systemic defects.
  • Emphasizes the need for a comprehensive evaluation beyond the eyes.
  • Underscores the importance of a multidisciplinary approach for optimal patient care and treatment outcomes.
Abstract

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Genetic Lingo01:11

Genetic Lingo

Overview
Focusing of Light in the Eye01:16

Focusing of Light in the Eye

Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...